Marleen Nys

Long‐term safety and efficacy of abatacept in children with juvenile idiopathic arthritis

Nicolino Ruperto, Daniel J. Lovell, Pierre Quartier et al. · Arthritis & Rheumatism · 2010 · 228 citations

Efficacy and safety of abatacept, a T-cell modulator, in a randomised, double-blind, placebo-controlled, phase III study in psoriatic arthritis

Philip J. Mease, Alice B. Gottlieb, Désirée van der Heijde et al. · Annals of the Rheumatic Diseases · 2017 · 212 citations · Full text

A Multicenter, Randomized, Double-Blind Study of the Effects of Aripiprazole in Overweight Subjects With Schizophrenia or Schizoaffective Disorder Switched From Olanzapine

John W. Newcomer, João Alberto de Oliveira Campos, Ronald N. Marcus et al. · The Journal of Clinical Psychiatry · 2008 · 131 citations

Efficacy and safety of abatacept in active primary Sjögren's syndrome: results of a phase III, randomised, placebo-controlled trial

Alan N. Baer, Jacques‐Eric Gottenberg, E. William St. Clair et al. · Annals of the Rheumatic Diseases · 2020 · 120 citations · Full text

A randomised, double-blind comparison of the angiotensin II receptor antagonist, irbesartan, with the full dose range of enalapril for the treatment of mild-to-moderate hypertension

A Mimran, Luís M. Ruilope, Linda Kerwin et al. · Journal of Human Hypertension · 1998 · 87 citations

Hypertension, Cardiovascular Disease, Antihypertensive Agents +9